Lead Identification & Optimization topic: New approach methodologies for immunogenicity risk assessment and functional evaluation of drug candidates
02 Sept 2026
ADC Linker Design & Conjugation Technologies
- In silico and in vitro immunogenicity assessment as a de-risking strategy
- Approaches to mitigate the unwanted immunogenicity of therapeutic proteins
- Designing low immunogenic antibodies
- In vitro Functional testing of lead candidates
